217 related articles for article (PubMed ID: 26026174)
1. The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.
Ambasta A; Carson J; Church DL
Med Mycol; 2015 Aug; 53(6):531-57. PubMed ID: 26026174
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
3. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
Danylo A; Courtemanche C; Pelletier R; Boudreault AA
Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
[TBL] [Abstract][Full Text] [Related]
4. Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients.
Bellanger AP; Millon L; Berceanu A; Grenouillet F; Grenouillet FE; Larosa F; Deconinck E
Med Mycol; 2015 Sep; 53(7):760-4. PubMed ID: 26162471
[TBL] [Abstract][Full Text] [Related]
5. Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.
Aslan M; Oz Y; Aksit F; Akay OM
Mycoses; 2015 Jun; 58(6):343-9. PubMed ID: 25851634
[TBL] [Abstract][Full Text] [Related]
6. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients.
Badiee P; Alborzi A; Karimi M; Pourabbas B; Haddadi P; Mardaneh J; Moieni M
J Infect Dev Ctries; 2012 Apr; 6(4):352-7. PubMed ID: 22505446
[TBL] [Abstract][Full Text] [Related]
8. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of invasive aspergillosis: recent developments and ongoing challenges.
Arvanitis M; Mylonakis E
Eur J Clin Invest; 2015 Jun; 45(6):646-52. PubMed ID: 25851301
[TBL] [Abstract][Full Text] [Related]
10. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
McCulloch E; Ramage G; Rajendran R; Lappin DF; Jones B; Warn P; Shrief R; Kirkpatrick WR; Patterson TF; Williams C
J Clin Pathol; 2012 Jan; 65(1):83-6. PubMed ID: 22049217
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.
Reinwald M; Konietzka CA; Kolve H; Uhlenbrock S; Ahlke E; Hummel M; Spiess B; Hofmann WK; Buchheidt D; Groll AH
Mycoses; 2014 Sep; 57(9):537-43. PubMed ID: 24655146
[TBL] [Abstract][Full Text] [Related]
12. Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?
Buchheidt D; Reinwald M; Spiess B; Boch T; Hofmann WK; Groll AH; Lehrnbecher T;
Mycoses; 2016 Feb; 59(2):67-74. PubMed ID: 26756571
[TBL] [Abstract][Full Text] [Related]
13. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis.
Desai R; Ross LA; Hoffman JA
Pediatr Infect Dis J; 2009 Apr; 28(4):283-6. PubMed ID: 19238113
[TBL] [Abstract][Full Text] [Related]
14. Aspergillus PCR formidable challenges and progress.
Klingspor L; Loeffler J
Med Mycol; 2009; 47 Suppl 1():S241-7. PubMed ID: 19253138
[TBL] [Abstract][Full Text] [Related]
15. Non-cultural methods for the diagnosis of invasive fungal disease.
Mikulska M; Furfaro E; Viscoli C
Expert Rev Anti Infect Ther; 2015 Jan; 13(1):103-17. PubMed ID: 25385534
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of invasive pulmonary aspergillosis: updates and recommendations.
Desoubeaux G; Bailly É; Chandenier J
Med Mal Infect; 2014 Mar; 44(3):89-101. PubMed ID: 24548415
[TBL] [Abstract][Full Text] [Related]
18. Current challenges in the microbiological diagnosis of invasive aspergillosis.
Guinea J; Bouza E
Mycopathologia; 2014 Dec; 178(5-6):403-16. PubMed ID: 24947167
[TBL] [Abstract][Full Text] [Related]
19. The current management landscape: aspergillosis.
Maertens JA; Blennow O; Duarte RF; Muñoz P
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii23-ii29. PubMed ID: 27880666
[TBL] [Abstract][Full Text] [Related]
20. Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis.
Vidal-García M; Domingo MP; De Rueda B; Roc L; Delgado MP; Revillo MJ; Pardo J; Gálvez EM; Rezusta A
Appl Microbiol Biotechnol; 2016 Mar; 100(5):2327-34. PubMed ID: 26678078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
